We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.3%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
+$1.1B
(+9.4%)
Cap. Flow
+$840M
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
12.13%
Holding
2,105
New
79
Increased
1,204
Reduced
715
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$16.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$15.2M |
| 3 |
AT&T
T
|
+$14.3M |
| 4 |
ExxonMobil
XOM
|
+$14.1M |
| 5 |
IBM
IBM
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$21.6M |
| 2 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$12.3M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$11.1M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$7.05M |
| 5 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$6.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Healthcare | 14.47% |
| 3 | Technology | 14.27% |
| 4 | Communication Services | 9.94% |
| 5 | Consumer Staples | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Sally Beauty Holdings
SBH
$1.5B
| $618K | ﹤0.01% |
21,030
-6,248
| -23% | -$187K |
|
1277
Associated Banc-Corp
ASB
$5.62B
| $615K | ﹤0.01% |
35,856
-2,042
| -5% | -$36.3K |
|
1278
Crane NXT
CXT
$2.72B
| $614K | ﹤0.01% |
31,180
-1,917
| -6% | -$37.4K |
|
|
AAV
1279
DELISTED
Advantage Oil & Gas Ltd
AAV
| $613K | ﹤0.01% |
109,638
-5,242
| -5% | -$29.2K |
|
1280
CEMIG Preferred Shares
CIG
$6.18B
| $611K | ﹤0.01% |
542,656
-19,569
| -3% | -$17.9K |
|
1281
Mercury Insurance
MCY
$5.65B
| $610K | ﹤0.01% |
11,476
+2,146
| +23% | +$113K |
|
|
USG
1282
DELISTED
Usg
USG
| $610K | ﹤0.01% |
22,610
+4,887
| +28% | +$133K |
|
1283
Kennametal
KMT
$2.27B
| $609K | ﹤0.01% |
27,531
+1,945
| +8% | +$45.9K |
|
1284
TIM SA
TIMB
$9.05B
| $608K | ﹤0.01% |
57,656
+2,718
| +5% | +$27.9K |
|
1285
CACI
CACI
$13.9B
| $607K | ﹤0.01% |
6,709
-201
| -3% | -$20K |
|
|
AMSG
1286
DELISTED
Amsurg Corp
AMSG
| $604K | ﹤0.01% |
7,785
-166
| -2% | -$12.8K |
|
1287
Enerpac Tool Group
EPAC
$1.83B
| $601K | ﹤0.01% |
26,565
+1,806
| +7% | +$46.4K |
|
1288
Franklin Electric
FELE
$4.25B
| $601K | ﹤0.01% |
18,187
+1,985
| +12% | +$64.8K |
|
|
OPLN
1289
Openlane
OPLN
$4.28B
| $601K | ﹤0.01% |
38,058
+8,423
| +28% | +$126K |
|
1290
ATI
ATI
$25.8B
| $598K | ﹤0.01% |
46,913
+2,791
| +6% | +$39.9K |
|
|
AVNS
1291
DELISTED
Avanos Medical
AVNS
| $598K | ﹤0.01% |
18,394
+2,342
| +15% | +$71.7K |
|
|
TRQ
1292
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $598K | ﹤0.01% |
17,682
+1,125
| +7% | +$32.6K |
|
1293
Littelfuse
LFUS
$10.1B
| $597K | ﹤0.01% |
5,055
-182
| -3% | -$21.2K |
|
1294
W.P. Carey
WPC
$15.2B
| $596K | ﹤0.01% |
8,767
+567
| +7% | +$35.6K |
|
|
HRC
1295
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $595K | ﹤0.01% |
11,791
-271
| -2% | -$13.7K |
|
|
PDCE
1296
DELISTED
PDC Energy, Inc.
PDCE
| $593K | ﹤0.01% |
10,296
-2,033
| -16% | -$121K |
|
1297
Brunswick
BC
$4.39B
| $591K | ﹤0.01% |
13,025
+809
| +7% | +$38.3K |
|
|
GTY
1298
Getty Realty Corp
GTY
$1.86B
| $591K | ﹤0.01% |
27,568
-1,407
| -5% | -$28.8K |
|
1299
Madison Square Garden
MSGS
$9.48B
| $591K | ﹤0.01% |
4,800
-110
| -2% | -$12.9K |
|
1300
Cognex
CGNX
$10.1B
| $590K | ﹤0.01% |
27,360
+2,724
| +11% | +$54.9K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q2 2016 Portfolio in Review
As of Q2 2016, Aperio Group held 2,105 positions worth $12.8B, up 9.4% from $11.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Aperio Group deployed $840M of net new capital in Q2 2016, opening 79 new positions and adding to 1,204 existing holdings. Its largest new stake was S&P Global: 119,543 shares worth $12.8M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $6.43M trimmed.
- Aperio Group's largest Q2 2016 buy was S&P Global: 119,543 shares worth $12.8M.
- Aperio Group added most to Novartis in Q2 2016, an estimated $16.2M increase.
- Aperio Group's biggest Q2 2016 reduction was Zimmer Biomet, cutting an estimated $6.43M.
- Aperio Group fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $21.6M.
- Aperio Group's ten largest holdings make up 12% of its $12.8B portfolio in Q2 2016.
- Aperio Group opened 79 new positions and closed 98 in Q2 2016.
- Aperio Group's portfolio value rose 9.4% quarter-over-quarter to $12.8B.
Based on Aperio Group's 13F filing for Q2 2016, filed 12 Aug 2016.